XML 41 R45.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation (Details 1) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2018
Sep. 30, 2019
Number of Options    
Outstanding at December 31, 2017 365,716 368,216
Granted 2,500 675,667
Exercised (198,043)
Forfeited/Cancelled
Outstanding at September 30, 2018 368,216 845,840
Vested and exercisable at September 30, 2019   458,311
Weighted Average Exercise Price    
Outstanding at December 31, 2017 $ 0.03 $ 0.07
Granted 5.34 2.32
Exercised 0.27
Forfeited/Cancelled
Outstanding at September 30, 2018 $ 0.07 1.82
Vested and exercisable at September 30, 2019   $ 1.42
Weighted Average Remaining Contractual Term (years)    
Outstanding at December 31, 2017 9 years 3 months 19 days  
Outstanding at September 30, 2018 8 years 7 months 6 days 9 years
Vested and exercisable at September 30, 2019   8 years 8 months 12 days
Aggregate Intrinsic Value    
Outstanding at December 31, 2017 [1] $ 908,920 $ 820,862
Outstanding at September 30, 2018 [1] $ 820,862 343,406
Vested and exercisable at September 30, 2019 [1]   $ 343,406
[1] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the estimated fair value of our common stock as of September 30, 2019 and 2018 of $1.87 and $2.30 per share, respectively. As of September 30, 2019, 658,730 and 271,201 outstanding and vested options, respectively, have no intrinsic value.